text size: T | T
Back to Snapshot
Company Description

Contact Info

One Johnson & Johnson Plaza

New Brunswick, NJ 08933

United States

Phone: 732-524-0400

Fax:

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture and sale of a range of products in the health care field worldwide. The company’s primary focus is products related to human health and well-being. The business of the company is conducted by approximately 250 operating companies located in 60 countries, including the U.S. Segments The company’s segments include Consumer, Pharmaceutical and Medical Devices. Consumer The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets. Baby Care includes the JOHNSON’S line of products. Oral Care includes the LISTERINE product line. Major brands in Skin Care include the AVEENO; CLEAN & CLEAR; DABAO; JOHNSON’S Adult; LE PETITE MARSEILLAIS; LUBRIDERM; NEUTROGENA; and RoC product lines. Over-the-counter medicines include the family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; and the PEPCID line of heartburn products. Major brands in Women’s Health outside of North America are STAYFREE and CAREFREE sanitary pads and o.b. tampon brands. Wound Care brands include the BAND-AID Brand Adhesive Bandages and NEOSPORIN First Aid product lines. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. Pharmaceutical The Pharmaceutical segment is focused on five therapeutic areas: immunology (rheumatoid arthritis, inflammatory bowel disease, and psoriasis), infectious diseases and vaccines (HIV, hepatitis, respiratory infections, and tuberculosis), neuroscience (Alzheimer's disease, mood disorders, and schizophrenia), oncology (prostate cancer, hematologic malignancies, and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes). Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. Key products in the Pharmaceutical segment include: REMICADE (infliximab), a treatment for a number of immune-mediated inflammatory diseases; SIMPONI (golimumab), a subcutaneous treatment for adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis and moderately active to severely active ulcerative colitis; SIMPONI ARIA (golimumab), an intravenous treatment for adults with moderate to severe rheumatoid arthritis; STELARA (ustekinumab), a treatment for adults with moderate to severe plaque psoriasis and active psoriatic arthritis, and for adolescents with moderate to severe psoriasis; OLYSIO/SOVRIAD(simeprevir), for combination treatment of chronic hepatitis C in adult patients; PREZISTA (darunavir), EDURANT (rilpivirine), and PREZCOBIX/REZOLSTA (darunavir/cobicistat), antiretroviral medicines for the treatment of human immunodeficiency virus (HIV-1) in combination with other antiretroviral products; SIRTURO (bedaquiline), a diarylquinoline antimycobacterial drug indicated as part of combination therapy in adults (>

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JNJ.
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 23.1x
Price/Sales 4.8x
Price/Book 4.7x
Price/Cash Flow 22.5x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.